2026

Adaptive bridging and holding therapy frequently reduces tumor burden and is associated with reduced toxicity after CAR-T cell therapy in multiple myeloma: A single-center real-world experience
Artzenroth J, Kosch R, Al-Bazaz M, Bartke L, Cords L, Güsmer C, Harzer M, Heinrich F, Kamili A, Leypoldt L, Madanchi R, Monin M, Schaefers C, Schlemmer T, Seibel J, Bokemeyer C, Weisel K, Alsdorf W
TRANSPL CELL THER. 2026 [Epub ahead of print].

2025

HER2 Expression in Desmoplastic Small Round Cell Tumor (DSRCT) as a Potential Therapeutic Target: A Case Report and Its Context
Hammada M, Striefler J, Duprée A, Priemel M, Schlemmer T, Hippen M, Christopeit M, Lübke A, Alsdorf W, Bokemeyer C, Sieb J, Peters M, Fröhling S, Telenau M
ONCOL RES TREAT. 2025;48((suppl 2)):278.

Letzte Aktualisierung aus dem FIS: 22.09.2026 - 00:36 Uhr